Theranos has created an eight-member Technology Advisory Board to serve as a counterpart to its Science and Medical Advisory Board. Channing Robertson and Howie Rosen will colead the new board. Robertson is the Ruth G. and William K. Bowes professor (Emeritus) in the School of Engineering at Stanford University. Rosen is CEO of AcelRx Pharmaceuticals.
Also on the board are Harvey Blanch, John Moalli, Allen Northrup, Clint Ostrander, Norbert Pelc, and Mark Prausnitz. Blanch is the Merck professor (Emeritus) of biochemical engineering at the University of California, Berkeley. Moalli is the acting head of product at Theranos and a principal at Exponent.
Northrup is a cofounder of Cepheid, while Ostrander is the former CEO and president of Kozio. Pelc is a professor of bioengineering and radiology and chair of bioengineering at Stanford, and Prausnitz is regents' professor and J. Erskine Love Jr. Chair in chemical and biomolecular engineering at the Georgia Institute of Technology, with an adjunct faculty appointment at Emory University School of Medicine.